A prospective randomized open-label trial of sirolimus versus paclitaxel-coated balloons for the side branch of de novo coronary bifurcation lesion
Qiyue Gao, Chi Liu, Guidong Xu, Xiaoping Peng, Xiaomin Chen, Xiantao Song, Rui Jing, Haiqiang Sang, Hong Jiang, Zuyi Yuan, Ranzun Zhao, Changling Li, Qiyuan Xu · 2025
Read A prospective randomized open-label trial of sirolimus versus paclitaxel-coated balloons for the side branch of de novo coronary bifurcation lesion by Qiyue Gao, Chi Liu, Guidong Xu, Xiaoping Peng, Xiaomin Chen, Xiantao Song, Rui Jing, Haiqiang Sang, Hong Jiang, Zuyi Yuan, Ranzun Zhao, Changling Li, Qiyuan Xu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12780450.txt.
Description
Gao leads a large team comparing two drug coated balloons for heart artery branches, in work from twenty twenty-five. When a heart artery splits, the main branch often gets a stent and the side branch gets a drug balloon. Two drug types are in common use.
The prospective randomized trial was held at many centers. Patients with fresh, non left main split lesions were split evenly between sirolimus and paclitaxel balloons for the side branch. The main check was narrowing of the treated spot on angiogram nine months later. A non inferiority design asks whether the newer drug is no worse than the standard by a set margin.
Catalog record
| CREATOR | Qiyue Gao, Chi Liu, Guidong Xu, Xiaoping Peng, Xiaomin Chen, Xiantao Song, Rui Jing, Haiqiang Sang, Hong Jiang, Zuyi Yuan, Ranzun Zhao, Changling Li, Qiyuan Xu |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |